Focus and Features of Prescribing Indications Spanning Multiple Chronic Conditions in Older Adults: A Narrative Review

Overview

Journal J Multimorb Comorb

Date 2022 May 27

PMID 35620567

Authors

Carole E Aubert

Eve A Kerr

Mandi L Klamerus

Timothy P Hofer

Melissa Y Wei

Affiliations

Soon will be listed here.

Abstract

Background: Inappropriate prescribing is frequent in older adults and associated with adverse outcomes. Prescribing indications aim to optimize prescribing, but little is known about the focus and features of prescribing indications for the most common chronic conditions in older adults. Understanding the conditions, medications, and issues addressed (e.g., patient perspective, drug-disease interaction, adverse drug event) in current prescribing indications may help to identify missing indications and develop standardized measures to improve prescribing quality.

Methods: We searched Ovid/MEDLINE and EMBASE for articles published between 2015 and 2020 reporting prescribing indications for older adults. Prescribing indication included 1) prescribing "criteria," or statements that guide prescribing action, and 2) prescribing "measures," or prescribing actions observed in a population. We categorized their focus by conditions, medications and issues addressed, as well as level of evidence provided.

Results: Among 16 sets of prescribing indications, we identified 748 criteria and 47 measures. The most common addressed medications were antihypertensives, analgesics/antirheumatics, and antiplatelets/anticoagulants. The most frequently addressed issues were drug-disease interaction, adverse drug event, administration, better therapeutic alternative, and (co-)prescription omission (20.8-36.1%). Age/functioning, drug-drug interaction, monitoring, and efficacy/safety ratio were found in only 9.9-16.5% of indications. Indications rarely focused on the patient perspective or issues with multiple providers.

Conclusion: Most prescribing indications for chronic conditions in older patients are criteria rather than measures. Indications accounting for patient perspective and multiple providers are limited. The gaps identified in this review may help improve the development of prescribing measures for older adults and ultimately improve quality of care.

Citing Articles

Challenges and barriers to physician decision-making for prescribing and deprescribing among patients with multimorbidity in eastern China's primary care settings: a qualitative study.

Zhou X, Han L, Farmer A, Yao M, Xia Y, Yan M BMJ Open. 2025; 15(2):e095063.

PMID: 39922587 PMC: 11808900. DOI: 10.1136/bmjopen-2024-095063.

Development and validation of new multimorbidity-weighted index for ICD-10-coded electronic health record and claims data: an observational study.

Wei M, Leis A, Vasilyev A, Kang A BMJ Open. 2024; 14(2):e074390.

PMID: 38365301 PMC: 10875470. DOI: 10.1136/bmjopen-2023-074390.

References

Tommelein E, Petrovic M, Somers A, Mehuys E, Van Der Cammen T, Boussery K . Older patients' prescriptions screening in the community pharmacy: development of the Ghent Older People's Prescriptions community Pharmacy Screening (GheOP³S) tool. J Public Health (Oxf). 2015; 38(2):e158-70. DOI: 10.1093/pubmed/fdv090. View

Motter F, Hilmer S, Paniz V . Pain and Inflammation Management in Older Adults: A Brazilian Consensus of Potentially Inappropriate Medication and Their Alternative Therapies. Front Pharmacol. 2019; 10:1408. PMC: 6901010. DOI: 10.3389/fphar.2019.01408. View

OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View

Rodriguez-Perez A, Alfaro-Lara E, Albinana-Perez S, Nieto-Martin M, Diez-Manglano J, Perez-Guerrero C . Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria. Geriatr Gerontol Int. 2017; 17(11):2200-2207. DOI: 10.1111/ggi.13062. View

Hamilton H, Gallagher P, Ryan C, Byrne S, OMahony D . Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011; 171(11):1013-9. DOI: 10.1001/archinternmed.2011.215. View

Mast R, Ahmad A, Hoogenboom S, Cambach W, Elders P, Nijpels G . Amsterdam tool for clinical medication review: development and testing of a comprehensive tool for pharmacists and general practitioners. BMC Res Notes. 2015; 8:642. PMC: 4632353. DOI: 10.1186/s13104-015-1566-1. View

. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019; 67(4):674-694. DOI: 10.1111/jgs.15767. View

Gallagher P, Barry P, OMahony D . Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007; 32(2):113-21. DOI: 10.1111/j.1365-2710.2007.00793.x. View

Saini S, Vijan S, Schoenfeld P, Powell A, Moser S, Kerr E . Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014; 348:g1247. PMC: 3935739. DOI: 10.1136/bmj.g1247. View

10.

Levinson W, Born K, Wolfson D . Choosing Wisely Campaigns: A Work in Progress. JAMA. 2018; 319(19):1975-1976. DOI: 10.1001/jama.2018.2202. View

11.

Fauziyah S, Andrajati R, Sartika R, Radji M . Adaptation and Validation of the Screening Tool of Older People's Prescriptions Instrument for the Indonesian Population. J Res Pharm Pract. 2020; 9(1):24-29. PMC: 7235452. DOI: 10.4103/jrpp.JRPP_19_106. View

12.

Guyatt G, Oxman A, Akl E, Kunz R, Vist G, Brozek J . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011; 64(4):383-94. DOI: 10.1016/j.jclinepi.2010.04.026. View

13.

Dang C, Toh L, Cooling N, Jackson S, Curtain C, Thompson A . Updating and validating quality prescribing indicators for use in Australian general practice. Aust J Prim Health. 2019; 26:31-42. DOI: 10.1071/PY19060. View

14.

Asch S, McGlynn E, Hogan M, Hayward R, Shekelle P, Rubenstein L . Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med. 2004; 141(12):938-45. DOI: 10.7326/0003-4819-141-12-200412210-00010. View

15.

Barnett K, Mercer S, Norbury M, Watt G, Wyke S, Guthrie B . Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380(9836):37-43. DOI: 10.1016/S0140-6736(12)60240-2. View

16.

du Vaure C, Dechartres A, Battin C, Ravaud P, Boutron I . Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details. BMJ Open. 2016; 6(9):e012265. PMC: 5051474. DOI: 10.1136/bmjopen-2016-012265. View

17.

Aubert C, Streit S, da Costa B, Collet T, Cornuz J, Gaspoz J . Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med. 2016; 35:35-42. DOI: 10.1016/j.ejim.2016.05.022. View

18.

Grimshaw J, Patey A, Kirkham K, Hall A, Dowling S, Rodondi N . De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Qual Saf. 2020; 29(5):409-417. PMC: 7229903. DOI: 10.1136/bmjqs-2019-010060. View

19.

Onder G, van der Cammen T, Petrovic M, Somers A, Rajkumar C . Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013; 42(3):284-91. DOI: 10.1093/ageing/aft038. View

20.

Chang C, Lai H, Hwang S, Yang S, Wu R, Chang L . The updated PIM-Taiwan criteria: a list of potentially inappropriate medications in older people. Ther Adv Chronic Dis. 2019; 10:2040622319879602. PMC: 6779000. DOI: 10.1177/2040622319879602. View